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Aloe vera is used worldwide for several medical purposes as alternative medicine. 
There are positive and negative reports on the hypoglycaemic effects of this plant. 
From previous acute studies, Aloe leaf gel and pulp extracts lead to significant 
decreases in blood glucose in neonatal streptozotocin (n0-STZ)-treated type-II 
diabetic rats, whereas lowering of blood glucose during chronic treatment with 
the same extracts was statistically insignificant. Here we try to detect whether 
Aloe leaf gel and pulp extracts affect pancreatic β-cells. Using n0-STZ type-II 
diabetic rats, the immunoreactivity of β-cells of the islets of Langerhans did not 
differ among treatments of control, glibenclamide-, Aloe vera leaf pulp- and gel 
extract-treated rats. These results suggest that treatment of diabetic rats with Aloe 
vera gel or pulp or glibenclamide has no beneficial influence on the pancreatic β-
cells in type II diabetes.  





Aloe vera L. Burm. f. or Aloe barbadensis Miller (Liliaceae) is native of North Africa and also 
cultivated in Turkey. This miraculous plant has been used in the traditional medicinal practices 
of many cultures for a host of curative purposes (Capasso et al. 1998, Vogler & Ernst 1999). 
Although oral hypoglycaemic agents are effective in controlling hyperglycaemia, they have 
prominent side effects (Rang et al. 1999). This leads to increasing demand for herbal products 
plant with antidiabetic activity and fewer side effects (Shane-Whorter 2001, Grover et al. 2002, 
Vetrichelvan & Jegadeesan 2002). In experimental diabetes, streptozotocin (STZ) causes 
selective degeneration of pancreatic β-cells thereby inhibiting insulin secretion. A. vera has 
also been shown to have antidiabetic and hypoglycaemic properties (Agarwal 1985, Hikino et 
al. 1986, Ghannam et al. 1986, Ajabnoor 1990, Beppu et al. 1993, Okyar et al. 2001a).  It was 
postulated that hypoglycaemic effect of  A. vera could be mediated through stimulation of 
synthesis and/or release of insulin from the β-cells of Langerhans (Ajabnoor 1990). However, 
                                                 
 




    
the mechanism of the reduction in mean glucose levels produced by A. vera has not been yet 
elucidated. 
 Some plant extracts shown to have hypoglycaemic activity have been tested for their 
activity on pancreatic β-cells: chard (Beta vulgaris L. var. cicla) (Bolkent et al. 2000), Aegle 
marmelose (Das et al. 1996), Anastatica hierochuntica (Rahmy & El-Ridi 2002) extracts were 
reported to improve the funtional state of pancreatic β-cells and thus reduce the histopathology 
provoked by STZ. In a recent study, prevention of the destruction of pancreatic islets by Aloe 
arborescens (Kidachi aloe) boiled-leaf-skin components was attributed to its free radical 
scavenging effect (Beppu et al. 2003). 
 To date, research on traditional antidiabetic plants has been especially focused on STZ-
induced type-I diabetic rats. It has been assumed that, as an alternative to oral hypoglycaemic 
agents, herbal medicine can only be effective in type-II diabetes where pancreatic islets have 
not been not totally destroyed. This is the reason that neontal STZ-induced (n0-STZ) type-II 
diabetic rats (Bonner-Weir et al. 1981) were used in our investigation, and also why 
glibenclamide, a known hypoglycaemic agent, was used for comparison.  
 The aim of the present work was to evaluate the effects of Aloe vera leaf pulp and gel 
extracts as well as glibenclamide on the pancreatic β-cells morphology in STZ-induced type II 
diabetic rats  
 
MATERIALS AND METHODS 
Specimens of Aloe vera (L.) Burm. f. (Arabic: Sabr, Sabar, Saber; Turkish: Sarisabir) were 
collected from Kale (Demre) in Antalya in May 1993 (a voucher specimen was deposited in 
the Herbarium of Istanbul University, Faculty of Pharmacy. ISTE No. 65118), planted and 
cultivated in the greenhouse of the Faculty of Pharmacy. Fresh leaves of this cultivated plant 
were used in this study.  Six large leaves were washed and cut from the middle, and the gel 
was separated. To prepare the leaf-pulp extract, the leaves without the gel (leaf pulp) were cut 
into small pieces (514 g) and homogenized with phosphate-buffered saline (PBS: pH 7; 600 
ml) by means of a Moulinex Masterchief blender. The extract was kept at 4oC overnight, then 
filtered through cloth and the filtrate centrifuged at 20,000 rpm for 30 min. at 2oC in a 
refrigerated centrifuge (Cryofuge 20-3 Heraeus-Christ). The green pellet was discarded and the 
clear yellow supernatant taken and lyophilized (using a Labconco apparatus). Thus 29 g of 
leaf-pulp extract was obtained. For use, leaf-pulp extract (7.5 %) was prepared by dissolving 
the powder in PBS and mixing thoroughly using a magnetic stirrer.  
The leaf-gel extract was prepared as follows. The gel (400 g = 2.5 g dry matter) was 
homogenized in a Waring blender, then diluted with PBS (300 ml) and homogenized for a 
second time. The extract was kept at 4oC overnight, and filtered through cloth. The clear 
filtrate  was kept at –20oC in small portions.  
 Glibenclamide (provided from Nobel; 5 mg) was suspended in 21 ml PBS; 4 ml 
propylene glycol was added and the mixture kept in an ultrasonic water bath (47.6 kHz.) for 45 
min. until a homogenous suspension was obtained. 
To obtain Type-II diabetic model rats, neonate Wistar pups were injected 
intraperitoneally on day 2 after birth with STZ (n0-STZ rats), at a rate of 100 mg/kg, freshly 
dissolved in cold citrate buffer (1 mM, pH 4.5) according to Bonner-Weir  et al. (1981). This 
model of STZ-induced diabetes was reported by Portha et al. (1989) as potentially appropriate 
for investigations into diabetes pharmacotherapy. The animals were checked for the occurrence 
of diabetes after 6 weeks and the diabetics (fasting blood-glucose levels 104-170 mg/dl; mean 
137 mg/dl, also in accordance with the type-II diabetic model) were used in the experiment 
when they were 2 months old (90-120 g weight). The animals were fed with laboratory pellets 




    
and water ad libitum. Healthy (non-diabetic rats, 5 animals) were kept in the same conditions 
as the diabetic rats. Type-II diabetic rats were separated into  4 groups with  5-10  rats per 
group. Each group was given treatments as follows: Group I: (untreated diabetic control): PBS 
(6 ml/kg), Group II:  A. vera leaf-pulp extract (500 mg/kg), Group III: A. vera leaf-gel extract 
(10 ml=63 mg/kg), Group IV: glibenclamide (1 mg/kg). 
 Each group of animals was treated daily over 14 days orally by means of a catheter 
under mild ether anaesthesia. Blood glucose levels (non-fasting) (reported in Turkish in Okyar 
et al. 2001b, and summarized here) were determined on the 7th and 14th days (using 32 µl 
blood taken from the tail vein in capillary tubes: Ringcaps Reflotron®) by the Reflotron® 
(Boehringer-Mannheim) glucose-oxidase method using the strips provided. The animals were 
sacrificed on the 15th day.  
 Tissue pieces taken from the pancreas of the rats on the 15th day were fixed by Bouin’s 
solution and subsequently embedded in paraffin using routine procedures. The sections were 
dewaxed and rehydrated. After a washing step in PBS, they were immersed in 3 % H2O2 
solution for 10 min. The sections were then kept in serum-blocking solution for 10 min. After 
incubation of the sections in primary monoclonal anti-insulin antibody (dilution 1:1000 µg/ml 
Sigma code I-2018 ) at 4 °C for one hour, they were immunostained according to the 
streptavidin-biotin-peroxidase method. A histostain SP kit (Zymed code 95-9943, San 
Francisco) was used for the immunohistochemistry. The localization of the antigen was 
indicated by a red colour, obtained with 3-amino-9-ethyl-carbozole (AEC) chromogen. Slides 
were counterstained with hematoxylin. 
 For controls for the specificity of antibody, the primary antibody step was omitted, or 
an inappropriate antibody (gastrin) was used. Control pancreas sections with (+) signals were 




Blood glucose levels of the rats are summarized in Table 1 (from Okyar et al. 2001b): treated 
diabetic animals did not differ from diabetic controls.  
 
Table 1. Effect of Aloe vera leaf-pulp and gel extracts, and glibenclamide on blood glucose levels of type-II 
diabetic rats during chronic treatment (summarized from Okyar et al. 2001 b). There were no 




Blood glucose level  mg % 
 day 0 day 7 day 14 
Untreated non-diabetic 98.1 ± 7.4 90.5 ± 5.4 87.0 ± 6.5 
Untreated diabetic (PBS control)  
185.4 ± 34.0 
 
183.6 ± 43.0 
 
182.0 ± 31.9 
Aloe pulp 
202.7 ± 88.2 182.6 ± 68.4 229.0 ± 64.1 
Aloe gel 220.9 ± 63.5 205.6 ± 58.6 190.9 ± 67.7 
Glibenclamide 199.6 ± 64.8 167.4 ± 41.8 164.5 ± 66.7 
 
 No immunohistochemical reaction was observed in negative control sections (Fig.1). In 
the control healthy group, immunoreactivity was observed in all β-cells as compared with the 
diabetic group (Fig 2). Only about half of the β-cells in the diabetic group gave positive signals 




    
compared to the control group (Fig. 3). A decrease in the number of β-cells in this group was 
observed in comparison to the control group. The immunoreactivity of β-cells of the control 
diabetic group was not different from any of the treatmented groups: glibenclamide (Fig. 4), 
Aloe vera leaf gel (Fig. 5), or pulp extracts (Fig. 6). 
 
 
Fig. 1. Negative control (omission of primary antibody) section from control pancreatic islet. Counterstain 
haematoxylin. X 400. 
Fig. 2. Insulin immunoreactivity (►) in Langerhans islets of the control rat. Streptavidin-Biotin-Peroxidase 
technique. Counterstain haematoxylin. X 400. 
Fig. 3. Positive cells (►) in the pancreatic islet of the diabetic animal. Streptavidin-Biotin-Peroxidase technique. 
Counterstain haematoxylin. X 400. 
Fig. 4. Insulin-producing cells (►) in Langerhans islets of the diabetic rat given glibenclamide. Streptavidin-
Biotin-Peroxidase technique. Counterstain haematoxylin. X 400. 
Fig. 5. Immunoreactive B-cells (►) in the pancreatic islet of the diabetic animal given Aloe gel extract. 
Streptavidin-Biotin-Peroxidase technique. Counterstain haematoxylin. X 400. 
Fig. 6. Insulin immunoreactivity (►) in Langerhans islet of the diabetic rat given Aloe pulp extract. Streptavidin-
Biotin-Peroxidase technique. Counterstain haematoxylin. X 400.  




    
DISCUSSION 
 
In recent years, various plant extracts have been claimed to be useful for the cure of diabetes 
mellitus (Palanichamy et al. 1988, Bailey & Day 1989, Ivorra et al. 1989, Neef et al. 1995, 
Perez et al. 1998, Shukla et al. 2000, Bolkent et al. 2000) but few of them have been tested for 
their effects on tissues of diabetic animals (Kern & Engerman 1987, Palanichamy et al. 1988, 
Parinandi et al. 1990, Bolkent et al. 2000): parsley extracts did not cause any morphological 
changes in pancreatic β-cells (Yanardag et al. 2003). Acute treatment with Aloe leaf pulp 
resulted in 30 and 34% decreases in blood sugar levels of n0-STZ-diabetic rats, after 2 and 3 hr 
of administration of the extract respectively (Okyar et al. 2001a), and 11 and 14% reductions 
in blood glucose levels 3 and 4 hr after administration of Aloe leaf-gel extract.  
 However these effects could not be repeated with the same extracts in chronic treatment 
(Okyar et al. 2001b). There were no significant differences in blood glucose levels between the 
groups given Aloe leaf-pulp and gel extracts compared to the control group given PBS, and 
there were no significant differences in blood sugar levels between Aloe extracts compared 
with the group given glibenclamide (see Table 1). Alongside claims of  hypoglycaemic activity 
for Aloe extracts, (Agarwal 1985; Hikino et al. 1986; Ghannam et al. 1986; Ajabnoor 1990; 
Beppu et al. 1993; Okyar et al. 2001a), there are also reports of negative effects (Mossa 1985; 
Al-Awadi & Gumaa, 1987; Koo 1994; Chalaprawat 1997; Okyar  et al. 2001b). These may be 
due to variation in the content and quality of natural drugs as well as to differences in the 
animals studied. Further studies with well-defined preparations or pure compounds are needed 
to eliminate the confusion which still exists about Aloe preparations. In the present study, the 
fact that neither glibenclamide nor Aloe extracts showed any stimulation of the pancreatic β-
cells in type-II diabetic rats suggests that any decreases in blood glucose levels caused by Aloe 
extracts is not mediated by insulin release from β-cells, but  by extra-pancreatic usage of 
glucose. 
 Thus we conclude that, contrary to reports in the literature (Rang et al. 1999¸ Chitra et 
al. 1998), treatment of diabetic rats with Aloe vera (gel and pulp) extracts or glibenclamide has 
no beneficial influence on the pancreas and thus may not be appropriate for the treatment of 
type-II diabetes in alternative medicine.  
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